Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Burkitt Lymphoma × Diet Therapy × Clear all

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 2 Motor Activity 2 Colorectal Neoplasms 2 Stomach Neoplasms 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Postoperative Complications 1 Pancreatic Neoplasms 1 Overweight 1 Obesity 1 Neoplasms 1 Melanoma 1 Malnutrition 1 Lung Neoplasms 1 Leukemia 1 Hypothalamic Neoplasms 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 GastroEsophageal Cancer 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Intraductal, Noninfiltrating 1 Cachexia 1 Burkitt Lymphoma 1 Breast Carcinoma In Situ 1 Advanced Malignant Solid Neoplasm 1

Interventions

Cyclophosphamide 26 Prednisone 14 Vincristine 13 blinatumomab 12 fludarabine 11 Methotrexate 11 Specimen Handling 10 Rituximab 9 Cytarabine 9 prednylidene 8 deltacortene 8 Doxorubicin 8 Dexamethasone 8 venetoclax 7 merphos 7 Etoposide 7 CT-P10 7 Biopsy 7 Spinal Puncture 6 Mercaptopurine 6 Magnetic Resonance Spectroscopy 6 Asparaginase 6 fludarabine phosphate 5 azathiopurine 5 Inotuzumab Ozogamicin 5 Daunorubicin 5 obinutuzumab 4 dexamethasone acetate 4 dexamethasone 21-phosphate 4 auricularum 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06785324 2025-06-19

NEOMA ALL

University of Chicago

Phase NA Recruiting

Burkitt Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡